Suchergebnisse - "Wang, B"

PubPharm (49)

1

Expert consensus on the management of adverse events of CDK4/6 inhibitors in breast cancer

enthalten in: Zhonghua zhong liu za zhi [Chinese journal of oncology | 2022

von Ge, R. | Wang, B. | Jiang, Z. | +1

2

Expert consensus on the management of adverse events of ErbB family tyrosine kinase inhibitors in breast cancer

enthalten in: Zhonghua zhong liu za zhi [Chinese journal of oncology | 2020

von Wang, B. | Ge, R. | Jiang, Z. | +1

3

Rapamycin in the treatment of renal diseases associated with tuberous sclerosis complex

enthalten in: Zhonghua er ke za zhi = Chinese journal of pediatrics | 2019

von Dun, S. | Zou, L. | Zhang, M. | +10

4

Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas

enthalten in: Glia | 2017

von Herting, C. | Chen, Z. | Pitter, K. | +8

5

Effect of Δ40p53 isoform on enhancing the pro-apoptotic function of p53 in tumor cells

enthalten in: Zhonghua zhong liu za zhi [Chinese journal of oncology | 2017

von Wang, B. | Zhao, H. | Qiao, L. | +4

6

The effect of tanshinone ⅡA potentiates the effects of Cisplatin in Fadu cells in vitro through downregulation of survivin

enthalten in: Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery | 2017

von Zhao, Y. | Luo, D. | Zhang, Y. | +3

7

miR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop

enthalten in: Oncogene | 2017

von Shi, L. | Wang, Y. | Lu, Z. | +10

8

Advances in research on primary resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer patients

enthalten in: Zhonghua zhong liu za zhi [Chinese journal of oncology | 2016

von Yao, Y. | Wang, J. | Wang, B.

9

Engineered adenovirus fiber shaft fusion homotrimer of soluble TRAIL with enhanced stability and antitumor activity

enthalten in: Cell death & disease | 2016

von Yan, J. | Wang, L. | Wang, Z. | +10

10

Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML

enthalten in: Leukemia | 2016

von Wu, H. | Hu, C. | Wang, A. | +15

1
2
3
4
5
Nächster »
[5]